RP

Regeneron Pharmaceuticals

REGN

NASDAQHealth Care

Income Statement

Total Revenue$14.2B

Gross Profit$12.23B

Operating Income$3.99B

EBITDA$5.32B

EBIT$4.84B

Pre-tax Income$5.16B

Net Income$4.41B

Balance Sheet

Cash Equivalent$2.26B

Total Debt$2.7B

Book Value$28.47B

Book Value Per Share258.77

Key Ratios

Return on Equity (ROE)+15.03%

Return on Assets (ROA)+11.69%

Return on Invested Capital (ROI)+13.76%

Net Profit Margin+31.07%

Current Ratio4.73

Quick Ratio3.86

Long-Term Debt / Equity0.07